Stock Ideas
Stocks
Funds
Screener
Sectors
Watchlists
NUS

NUS - Nu Skin Enterprises Inc Stock Price, Fair Value and News

12.41USD+0.18 (+1.47%)Market Closed

Market Summary

NUS
USD12.41+0.18
Market Closed
1.47%

NUS Alerts

  • Big fall in Revenue (Y/Y)
  • Big fall in earnings (Y/Y)
  • Losses in recent quarter

NUS Stock Price

View Fullscreen

NUS RSI Chart

NUS Valuation

Market Cap

616.4M

Price/Earnings (Trailing)

-185.99

Price/Sales (Trailing)

0.32

EV/EBITDA

10.64

Price/Free Cashflow

7.27

NUS Price/Sales (Trailing)

NUS Profitability

EBT Margin

0.69%

Return on Equity

-0.41%

Return on Assets

-0.19%

Free Cashflow Yield

13.75%

NUS Fundamentals

NUS Revenue

Revenue (TTM)

1.9B

Rev. Growth (Yr)

-13.33%

Rev. Growth (Qtr)

-14.6%

NUS Earnings

Earnings (TTM)

-3.3M

Earnings Growth (Yr)

-104.69%

Earnings Growth (Qtr)

-107.32%

Breaking Down NUS Revenue

Last 7 days

-0.1%

Last 30 days

-9.0%

Last 90 days

0.9%

Trailing 12 Months

-61.8%

How does NUS drawdown profile look like?

NUS Financial Health

Current Ratio

2.09

Debt/Equity

0.56

Debt/Cashflow

0.32

NUS Investor Care

Buy Backs (1Y)

0.48%

Diluted EPS (TTM)

-0.07

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
20241.9B000
20232.1B2.0B2.0B2.0B
20222.6B2.5B2.4B2.2B
20212.7B2.8B2.8B2.7B
20202.3B2.3B2.4B2.6B
20192.7B2.6B2.5B2.4B
20182.4B2.6B2.7B2.7B
20172.2B2.2B2.1B2.3B
20162.2B2.2B2.2B2.2B
20152.4B2.4B2.3B2.2B
20143.3B3.3B3.0B2.6B
20132.2B2.3B2.7B3.2B
20121.8B2.0B2.0B2.1B
20111.6B1.6B1.6B1.7B
201001.4B1.5B1.5B
200901.3B1.3B1.3B
20080001.2B
GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed Russell 2000 Index

Small Caps and Mid Caps are mostly overlooked by investors as all the focus goes to Magnificent 7. These stocks that are not part of the beauty contest require a deeper look. However, all large cap stocks were once small caps. Grufity's Fair Value model opens up this unverse as it separates high-performing, rewarding stocks from low-performing risky stocks. <b>Russell 2000 stocks that were marked 'Very Cheap' by the model doubled in three years while the index was flat.</b>

PurpleZone


Returns of $10,000 invested in:

Very Cheap Stocks: $21,859
Russell 2000 Index: $10,334
Very Expensive Stocks: $8,224


Russell 2000 stocks considered 'Very Cheap' by the model greatly outperformed Russell 2000 index and the 'Very Expensive' bucket over past three years.

Russell 2000 Index
Very Expensive Stocks
Very Cheap Stocks
Try For Just $1.99

Tracking the Latest Insider Buys and Sells of Nu Skin Enterprises Inc

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
Jun 12, 2024
woodbury edwina d
acquired
91.49
13.07
7.00
-
Jun 07, 2024
nathanson laura
acquired
-
-
11,330
-
Jun 07, 2024
shen zheqing
acquired
-
-
11,330
-
Jun 07, 2024
thomas pisano r.
acquired
-
-
11,330
-
Jun 07, 2024
campbell daniel w
acquired
-
-
11,330
-
Jun 07, 2024
battle emma s.
acquired
-
-
11,330
-
Jun 07, 2024
woodbury edwina d
acquired
-
-
11,330
-
Jun 05, 2024
clark chayce david
sold (taxes)
-13,119
13.47
-974
evp and general counsel
Jun 05, 2024
hatchett steven keith
sold (taxes)
-6,182
13.47
-459
chief product officer
May 28, 2024
lipman andrew d
sold
-26,660
13.33
-2,000
-

1–10 of 50

Which funds bought or sold NUS recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
Jun 11, 2024
EverSource Wealth Advisors, LLC
reduced
-50.65
-15,672
6,680
-%
May 28, 2024
TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY
unchanged
-
-92,000
228,000
-%
May 20, 2024
EMC Capital Management
sold off
-100
-94,000
-
-%
May 16, 2024
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
reduced
-6.22
-340,156
683,880
-%
May 16, 2024
COMERICA BANK
reduced
-17.73
-207,359
293,348
-%
May 16, 2024
JANE STREET GROUP, LLC
added
113
677,324
1,977,940
-%
May 15, 2024
PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO
added
30.52
-4,118
54,297
-%
May 15, 2024
Voya Investment Management LLC
reduced
-19.85
-165,226
219,717
-%
May 15, 2024
Walleye Trading LLC
added
1,923
71,894
77,254
-%
May 15, 2024
Brevan Howard Capital Management LP
reduced
-15.3
-221,089
336,110
-%

1–10 of 42

Are Funds Buying or Selling NUS?

Are funds buying NUS calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own NUS
No. of Funds

Unveiling Nu Skin Enterprises Inc's Major ShareHolders

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 13, 2024
vanguard group inc
12.58%
6,215,151
SC 13G/A
Feb 09, 2024
invesco ltd.
5.8%
2,856,897
SC 13G
Feb 08, 2024
wellington management group llp
0.00%
0
SC 13G/A
Jan 25, 2024
state street corp
5.81%
2,871,749
SC 13G/A
Jan 22, 2024
blackrock inc.
17.2%
8,508,678
SC 13G/A
Aug 09, 2023
state street corp
6.11%
3,051,276
SC 13G/A
Feb 13, 2023
renaissance technologies llc
4.63%
2,287,596
SC 13G/A
Feb 09, 2023
vanguard group inc
13.13%
6,490,840
SC 13G/A
Feb 09, 2023
state street corp
14.94%
7,384,649
SC 13G/A
Feb 06, 2023
wellington management group llp
7.15%
3,535,969
SC 13G/A

Recent SEC filings of Nu Skin Enterprises Inc

View All Filings
Date Filed Form Type Document
Jun 20, 2024
144
Notice of Insider Sale Intent
Jun 13, 2024
4
Insider Trading
Jun 10, 2024
4
Insider Trading
Jun 10, 2024
4
Insider Trading
Jun 10, 2024
4
Insider Trading
Jun 10, 2024
4
Insider Trading
Jun 10, 2024
4
Insider Trading
Jun 10, 2024
4
Insider Trading
Jun 07, 2024
S-8 POS
Employee Benefits Plan
Jun 07, 2024
4
Insider Trading

Peers (Alternatives to Nu Skin Enterprises Inc)

NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
397.0B
84.1B
0.24% 12.18%
26.24
4.72
3.82% 5.63%
79.8B
19.8B
2.60% 24.64%
30.55
4.04
7.71% 63.39%
40.8B
15.3B
-13.03% -41.84%
61.6
2.66
-3.25% -39.29%
26.6B
5.9B
1.47% 11.62%
34.13
4.48
8.05% 89.02%
17.0B
7.2B
1.94% -12.88%
70.7
2.35
0.53% 224.32%
11.5B
1.0B
32.25% 82.45%
90.19
11.24
76.89% 107.48%
MID-CAP
8.6B
6.1B
-4.15% -19.79%
39.31
1.41
13.69% 13.11%
4.7B
959.4M
36.92% 165.47%
-2.0K
4.93
55.65% 96.05%
3.6B
1.3B
-4.90% -17.75%
25.8
2.71
15.88% -0.05%
2.8B
8.0B
-15.91% -14.71%
-9.44
0.35
-10.08% -121.80%
2.4B
2.0B
-6.71% 0.54%
13.95
1.17
-3.26% 17.67%
SMALL-CAP
2.0B
2.3B
-1.14% -6.85%
15.96
0.87
1.98% 28.45%
126.7M
190.6M
-12.05% 37.81%
6.87
0.66
-2.98% 477.15%
60.2M
241.3M
10.67% -7.26%
-1.79
0.25
-20.28% 37.16%
42.0M
11.6M
0.66% 7.02%
15.28
3.63
1.70% 13.94%

Nu Skin Enterprises Inc News

Latest updates
Yahoo Lifestyle UK19 Jun 202401:05 pm
See It Market11 Jun 202407:00 am
The Motley Fool4 months ago

Nu Skin Enterprises Inc Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)
(In Millions)
Income Statement (Quarterly)
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q1
Revenue-14.6%417489499500481522538561605673641704677748703612518583590624624
Gross Profit-16.6%294352292365348375364413443500482532506553520458392443450469477
Operating Expenses-15.2%285336319322332347385361391479417447444465446400356388380395408
  S&GA Expenses-15.3%154181188185188201216219243263260281276295281249206228232246250
EBITDA Margin-9.4%0.04*0.05*0.06*0.06*0.06*0.07*0.07*0.10*0.11*0.11*0.14*0.14*---------
Interest Expenses-7.00---5.00----------------
Income Taxes-22.5%2.002.003.0010.003.00-32.90-3.579.0012.0028.0018.0022.0017.0018.0018.0018.0011.0013.0021.0025.0023.00
Earnings Before Taxes-88.2%1.009.00-34.4537.0015.0024.00-28.9643.0051.0018.0068.0081.0064.0091.0075.0060.0030.0054.0065.0071.0066.00
EBT Margin-49.1%0.01*0.01*0.02*0.02*0.03*0.04*0.03*0.07*0.08*0.09*0.11*0.11*---------
Net Income-107.3%-0.537.00-36.9527.0011.0057.00-25.3934.0039.00-9.2350.0059.0047.0073.0056.0042.0020.0040.0044.0046.0043.00
Net Income Margin-139.9%0.00*0.00*0.03*0.03*0.04*0.05*0.02*0.05*0.05*0.05*0.08*0.08*---------
Free Cashflow-126.5%-8.9634.0039.0021.00-33.5612.003.0037.00-2.7491.0017.003.00---------
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q1
Assets-3.6%1,7421,8061,7931,8941,8251,8211,7631,9011,8921,9061,9742,0501,9501,9571,8171,7941,7461,7691,7371,7911,755
  Current Assets-7.8%647702701793774760778883849873891962901903772786730740739788748
    Cash Equivalents-17.0%213256233236230265294364302340282355339403367376353336320361310
  Inventory-5.3%265280291372367346327354382400415391363314270262257276283293304
  Net PPE-2.3%423433429430438445433443449454464474464468456445449454448443446
  Goodwill0%23123122920.00206206206206206206216216203203197197197197197197197
Liabilities-5.4%9329849719989329249219609589941,0381,1321,0791,0639891,002946894891956944
  Current Liabilities-5.9%309329434445373359366384494530541616562543466485420357368415402
  Long Term Debt-5.2%453478363368373377382387259269279288298305313320327334342349356
    LT Debt, Current20.0%30.0025.0014014048.0025.0043.0040.0011010811015390.0030.0030.0095.0095.0028.0025.0060.0045.00
    LT Debt, Non Current-5.2%453478363368373377382387259269279288298305313320327334342349356
Shareholder's Equity-1.4%810822822895893897842941934913936918871894827792800875846835811
  Retained Earnings-0.2%1,8671,8701,8821,9391,9311,9391,9011,9461,9311,9121,9401,9091,8691,8411,7861,7491,7271,7281,7081,6851,659
  Additional Paid-In Capital-0.5%619622619616611613610606599602591587579580570563558558557556553
Shares Outstanding-0.3%50.0050.0050.0050.0050.0050.0050.0050.0050.0050.0050.0050.00---------
Float----1,640---2,170---2,800---1,940---2,700-
Cashflow (Last 12 Months)
(In Thousands)
Cashflow (Quarterly)
(In Thousands)
(*) denotes actual numbers (not divided by Thousands)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q1
Cashflow From Operations-93.9%3,31854,16751,02735,522-22,07725,52528,44146,5557,541109,50930,21420,715-18,85694,693118,36797,05469,02749,90353,55182,663-8,186
  Share Based Compensation36.0%4,2423,1183,7254,8014,0023,0473,1712,0224,1276,7183,0936,5806,8038,6217,1154,8693,4552601,0153,5935,041
Cashflow From Investing39.8%-9,262-15,398-11,906-92,501-14,696-13,385-25,211-18,350-10,133-15,577-17,914-36,439-18,796-29,489-21,450-9,305-19,184-13,283-23,683-16,304-18,142
Cashflow From Financing-57.7%-31,955-20,265-38,37467,9891,380-50,794-61,10946,158-33,759-35,916-80,01929,388-18,155-41,839-110,794-69,554-22,979-25,552-62,570-13,705-52,967
  Dividend Payments-84.5%2,97919,26919,48619,47519,39219,02719,30319,39219,29318,93619,00719,04019,28919,10019,24519,35620,68620,55320,55220,55320,531
  Buy Backs---13,011--10,00740,02810,00410,00610,00510,00510,00450,40616,97319,99446,48160,886---825
Get Full Access to Grufity – and Unlimited Downloads
Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.
Try For Just $1.99

NUS Income Statement

2024-03-31
Consolidated Statements of Income (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Consolidated Statements of Income [Abstract]  
Revenue$ 417,306$ 481,462
Cost of sales123,242133,588
Gross profit294,064347,874
Operating expenses:  
Selling expenses153,542188,124
General and administrative expenses124,566133,899
Restructuring and impairment expenses7,1349,787
Total operating expenses285,242331,810
Operating income8,82216,064
Interest expense7,3254,888
Other income (expense), net(396)3,412
Income before provision for income taxes1,10114,588
Provision for income taxes1,6343,212
Net (loss) income$ (533)$ 11,376
Net (loss) income per share (Note 6):  
Basic (in dollars per share)$ (0.01)$ 0.23
Diluted (in dollars per share)$ (0.01)$ 0.23
Weighted-average common shares outstanding:  
Basic (in shares)49,53849,644
Diluted (in shares)49,53850,058

NUS Balance Sheet

2024-03-31
Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Current assets:  
Cash and cash equivalents$ 212,532$ 256,057
Current investments8,67411,759
Accounts receivable, net67,04172,879
Inventories, net265,100279,978
Prepaid expenses and other93,91381,198
Total current assets647,260701,871
Property and equipment, net422,818432,965
Operating lease right-of-use assets93,09290,107
Goodwill230,768230,768
Other intangible assets, net101,933105,309
Other assets246,044245,443
Total assets1,741,9151,806,463
Current liabilities:  
Accounts payable32,23743,505
Accrued expenses247,068260,366
Current portion of long-term debt30,00025,000
Total current liabilities309,305328,871
Operating lease liabilities74,19870,943
Long-term debt453,183478,040
Other liabilities95,023106,641
Total liabilities931,709984,495
Commitments and contingencies (Notes 5 and 11)
Stockholders' equity:  
Class A common stock - 500 million shares authorized, $0.001 par value, 90.6 million shares issued9191
Additional paid-in capital618,706621,853
Treasury stock, at cost - 40.9 million and 41.1 million shares(1,564,942)(1,570,440)
Accumulated other comprehensive loss(110,607)(100,006)
Retained earnings1,866,9581,870,470
Total stockholders' equity810,206821,968
Total liabilities and stockholders' equity$ 1,741,915$ 1,806,463
NUS
Nu Skin Enterprises, Inc., together with its subsidiaries, develops and distributes various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO, ageLOC Body Spa; and nutricentials skin care products. The company also provides wellness products, such as ageLOC Meta, LifePak nutritional supplements, ageLOC TR90 weight management system, and Beauty Focus Collagen+. In addition, it is involved in the research and product development of skin care products and nutritional supplements. The company sells its products under the Nu Skin, Pharmanex, and ageLOC brands through retail stores, website, digital platforms, and independent direct sellers and marketers, as well as a service center. Nu Skin Enterprises, Inc. was founded in 1984 and is headquartered in Provo, Utah.
 CEO
 WEBSITEnuskin.com
 INDUSTRYHousehold Products
 EMPLOYEES3800

Nu Skin Enterprises Inc Frequently Asked Questions


What is the ticker symbol for Nu Skin Enterprises Inc? What does NUS stand for in stocks?

NUS is the stock ticker symbol of Nu Skin Enterprises Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Nu Skin Enterprises Inc (NUS)?

As of Fri Jun 21 2024, market cap of Nu Skin Enterprises Inc is 616.37 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of NUS stock?

You can check NUS's fair value in chart for subscribers.

What is the fair value of NUS stock?

You can check NUS's fair value in chart for subscribers. The fair value of Nu Skin Enterprises Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Nu Skin Enterprises Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for NUS so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Nu Skin Enterprises Inc a good stock to buy?

The fair value guage provides a quick view whether NUS is over valued or under valued. Whether Nu Skin Enterprises Inc is cheap or expensive depends on the assumptions which impact Nu Skin Enterprises Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for NUS.

What is Nu Skin Enterprises Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri Jun 21 2024, NUS's PE ratio (Price to Earnings) is -185.99 and Price to Sales (PS) ratio is 0.32. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. NUS PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Nu Skin Enterprises Inc's stock?

In the past 10 years, Nu Skin Enterprises Inc has provided -0.143 (multiply by 100 for percentage) rate of return.